Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Making New Year's resolution to control diabetes

José Rodriguez often skipped breakfast and lunch only to eat a large dinner at the end of the day. Despite his erratic eating habits, Mr. Rodriguez thought he was healthy until a routine blood test revealed he had type 2 diabetes.

2 Jan 2015

Former baseball player describes his journey in diabetes management

Former professional player Dmitri Young impressed the baseball world when he appeared at a game this summer, having lost about 100 pounds since he last played in 2010.

31 Dec 2014

Study: Sugar molecule promotes spontaneous cancers in mice

While people who eat a lot of red meat are known to be at higher risk for certain cancers, other carnivores are not, prompting researchers at the University of California, San Diego School of Medicine to investigate the possible tumor-forming role of a sugar called Neu5Gc, which is naturally found in most mammals but not in humans.

30 Dec 2014

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

Based on its recent analysis of the influenza vaccines market, Frost & Sullivan recognises Protein Sciences with the 2013 Global New Product Innovation Award. Flublok is the world's first recombinant protein vaccine for the prevention of seasonal influenza disease to gain U.S. FDA approval.

29 Dec 2014

Negative health effects of severe obesity

The negative health effects of severe obesity are very well known and have been thoroughly documented, yet obesity levels in the United States continue to remain stubbornly high. Many of these repercussions are life threatening and include heart attack, stroke, and a greatly increased chance of developing cancer.

27 Dec 2014

FDA approves Novo Nordisk’s weight loss injection, Saxenda

Novo Nordisk today announced that the Food and Drug Administration (FDA) has approved the new drug application (NDA) for Saxenda® (liraglutide [rDNA origin] injection), the first once-daily glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management.

25 Dec 2014

ADA lowers BMI cut point for screening Asian Americans for type 2 diabetes

The American Diabetes Association announced today that they are lowering the Body Mass Index (BMI) cut point for which they recommend screening Asian Americans for type 2 diabetes. These new guidelines derives from a position statement that will be published in the January issue of Diabetes Care, showing that many Asian Americans develop type 2 diabetes at lower BMI levels than the population at large.

24 Dec 2014

Two hormones better than one for hypoglycaemia prevention with artificial pancreas

Artificial pancreas systems significantly improve glycaemic control in adolescents and adults with Type 1 diabetes, shows a head-to-head trial of single- and dual-hormone systems versus a conventional insulin pump.

22 Dec 2014

Novo Nordisk gets positive CHMP opinion for expanded use of Tresiba in children with diabetes

Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for expanded use of Tresiba® (insulin degludec) in children and adolescents aged one to 17 years with diabetes.

From Novo Nordisk 22 Dec 2014

Continued exposure to high blood sugars may impact brain function in young diabetic children

Investigators have found that young children with type 1 diabetes (T1D) have slower brain growth compared to children without diabetes. A new study, published in the December issue of Diabetes, now available ahead of print, suggests that continued exposure to hyperglycemia, or high blood sugars, may be detrimental to the developing brain.

19 Dec 2014

Only few older adults use apps to help manage Type 2 diabetes, says new study

Despite showing interest in web or mobile apps to help manage their Type 2 diabetes, only a small number of older adults actually use them, says a new study from the University of Waterloo. Approximately 2.2 million Canadians are living with Type 2 diabetes, 2 million of whom are age 50 or older.

19 Dec 2014

Lilly, Adocia team up to develop BioChaperone Lispro insulin for treatment of diabetes

Eli Lilly and Company and Adocia today announced a worldwide licensing collaboration focused on developing an ultra-rapid insulin, known as BioChaperone Lispro, for treatment in people with type 1 and type 2 diabetes.

19 Dec 2014

Findings show effective treatment for type 1 diabetes patients with severe hypoglycemia

Type 1 diabetes (T1D) patients who have developed low blood sugar (hypoglycemia) as a complication of insulin treatments over time are able to regain normal internal recognition of the condition after receiving pancreatic islet cell transplantation, according to a new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania, published online in Diabetes.

18 Dec 2014

Researchers examine why Mexican-Americans at increased risk for Type 2 diabetes

While people of Mexican ancestry are nearly twice as likely to develop Type 2 diabetes as people of European heritage, the majority of research in this area has focused on those of European origin.

18 Dec 2014

Study: Low glycemic diet does not improve insulin sensitivity or cardiovascular risk factors

Nutrition experts are continually debating the nutritional value of carbohydrate-containing foods and whether some are healthier than others. High carbohydrate foods are classified by how much they increase blood sugar; known as glycemic index. In new findings led by researchers at Brigham and Women's Hospital in Boston and Johns Hopkins University in Baltimore, researchers looked at glycemic index' effect on cardiovascular disease (CVD) and diabetes and found that low glycemic diets did not improve insulin sensitivity or cardiovascular risk factors.

16 Dec 2014

Joslin study could lead to improved anti-aging drugs

In a study published today by Nature, researchers at Joslin Diabetes Center used a microscopic worm (C. elegans) to identify a new path that could lead to drugs to slow aging and the chronic diseases that often accompany it--and might even lead to better cosmetics.

16 Dec 2014

ARA 290 drug reduces neuropathic pain in type 2 diabetic patients

Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2 diabetic patients. In an exploratory study conducted by Araim Pharmaceuticals, a biotech company developing novel treatments for chronic diseases, investigators also observed improvements in metabolic control in patients administered ARA 290.

16 Dec 2014

Study provides evidence for presence of enterovirus in pancreatic islets of type 1 diabetic patients

Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.

16 Dec 2014

ADIPOQ gene variations linked to colorectal cancer risk, new study reveals

Adiponectin, a collagen-like protein secreted by fat cells, derives from the ADIPOQ gene. Variations in this gene may increase risk for type 2 diabetes, cardiovascular disease, and various cancers. A new study that links specific variations in the ADIPOQ gene to either higher or lower colorectal cancer risk is published in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

15 Dec 2014

Researchers uncover mechanism that helps white fat cells to become browner

White adipose tissue stores excess calories as fat that can be released for use in other organs during fasting. Mammals also have small amounts of brown adipose tissue, which primarily acts as an effective fat burner for the production of heat. Now researchers from the University of Southern Denmark have uncovered the mechanism by which white fat cells from humans gets reprogrammed to become browner.

14 Dec 2014

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Making New Year's resolution to control diabetes

Former baseball player describes his journey in diabetes management

Study: Sugar molecule promotes spontaneous cancers in mice

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

Negative health effects of severe obesity

FDA approves Novo Nordisk’s weight loss injection, Saxenda

ADA lowers BMI cut point for screening Asian Americans for type 2 diabetes

Two hormones better than one for hypoglycaemia prevention with artificial pancreas

Novo Nordisk gets positive CHMP opinion for expanded use of Tresiba in children with diabetes

Continued exposure to high blood sugars may impact brain function in young diabetic children

Only few older adults use apps to help manage Type 2 diabetes, says new study

Lilly, Adocia team up to develop BioChaperone Lispro insulin for treatment of diabetes

Findings show effective treatment for type 1 diabetes patients with severe hypoglycemia

Researchers examine why Mexican-Americans at increased risk for Type 2 diabetes

Study: Low glycemic diet does not improve insulin sensitivity or cardiovascular risk factors

Joslin study could lead to improved anti-aging drugs

ARA 290 drug reduces neuropathic pain in type 2 diabetic patients

Study provides evidence for presence of enterovirus in pancreatic islets of type 1 diabetic patients

ADIPOQ gene variations linked to colorectal cancer risk, new study reveals

Researchers uncover mechanism that helps white fat cells to become browner

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in